SMYD3 and head and neck squamous cell carcinoma: Based on previously published work supporting that SMYD3 promotes the epithelial-mesenchymal transition (EMT) phenotype in breast, ovarian and colon carcinoma cells11, we sought to determine whether SMYD3 depletion decreases the invasive potential of HPV-negative HNSCC cells.